Abstract Volume:5 Issue-1 Year-2017 Original Research Articles
 |
Online ISSN : 2347 - 3215 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcret@gmail.com |
2Department of Pharmacology, Pushpagiri College of Pharmac, Thiruvalla-689107, Kerala, India
Epilepsy is a group of neurological diseases characterized by epileptic seizures. Levetiracetam is increasingly used as adjunctive anticonvulsant therapy. Levetiracetam is second generation anti epileptic drug. The present review is aimed on the estimation of serum total bilirubin level and hyponatremic effect associated with the use of levetiracetam therapy in epileptic patients. The clinical monitoring of the serum sodium levels is done to identify the development of hyponatremia associated with the use of levetiracetam. Asymptomatic elevation in serum total bilirubin is found in patients taking levetiracetam. The review provides clinical information about the incidence of hyponatremia and serum total bilirubin level associated with levetiracetam therapy.
How to cite this article:
Lincy Joseph, Mathew George, Lintu Mariam Joshua. 2017. Estimation of Serum Total Bilirubin Level and Hyponatremic Effect Associated with the Use of Levetiracetam Therapy in Epileptic Patients.Int.J.Curr.Res.Aca.Rev. 5(1): 94-97doi: http://dx.doi.org/10.20546/ijcrar.2017.501.011
Quick Navigation
- Print Article
- Full Text PDF
- How to Cite this Article
- on Google
- on Google Scholor
- Citation Alert By Google Scholar